Proteome expression and carbonylation changes during Trypanosoma cruzi infection and Chagas disease in rats

Molecular and Cellular Proteomics

Volumn 11, Issue 4, 2012, Pages

  Wen, Jian Jun ^a   Garg, Nisha Jain ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZNIDAZOLE; GELSOLIN; N TERT BUTYL ALPHA PHENYLNITRONE; PLASMA PROTEIN; PROTEOME; VIMENTIN; AMINE OXIDE; ANTITRYPANOSOMAL AGENT; BIOLOGICAL MARKER; CARDIAC MYOSIN; MYOSIN LIGHT CHAIN; MYOSIN LIGHT CHAIN 2; NITROIMIDAZOLE DERIVATIVE; PHENYL-N-TERT-BUTYLNITRONE; SCAVENGER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHAGAS DISEASE; DISEASE COURSE; HEART DISEASE; IMMUNITY; INFLAMMATION; LIPID METABOLISM; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CARBONYLATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEOMICS; RAT; ANIMAL; BLOOD; METABOLISM; SPRAGUE DAWLEY RAT; TRYPANOSOMA CRUZI;

RATTUS; TRYPANOSOMA CRUZI;

ANIMALS; BIOLOGICAL MARKERS; BLOOD PROTEINS; CARDIAC MYOSINS; CHAGAS DISEASE; CYCLIC N-OXIDES; FREE RADICAL SCAVENGERS; GELSOLIN; MYOSIN LIGHT CHAINS; NITROIMIDAZOLES; PROTEIN CARBONYLATION; PROTEOME; RATS; RATS, SPRAGUE-DAWLEY; TRYPANOCIDAL AGENTS; TRYPANOSOMA CRUZI; VIMENTIN;

EID: 84859851528     PISSN: 15359476     EISSN: 15359484     Source Type: Journal    
DOI: 10.1074/mcp.M111.010918     Document Type: Article

References (64)

1. World Health Organization (2006) Report of the Scientific Working Group on Chagas Disease, UNDP/World Bank/WHO, http://www.who.int/tdr/diseases/chagas/ swg-chagas.pdf. Accessed Nov. 10, 2011
2. World Health Organization (2010) Chagas disease: control and elimination. Report of the secretariat, UNDP/World Bank/WHO, http://apps.who.int/gb/ebwha/ pdf-files/WHA63/A63-17-en.pdf. Accessed Nov. 10, 2011
3. Bern, C., and Montgomery, S. P. (2009) An estimate of the burden of Chagas disease in the United States. Clin. Infect. Dis. 49, e52-54
4. Inglessis, I., Carrasco, H. A., Añez, N., Fuenmayor, C., Parada, H., Pacheco, J. A., and Carrasco, H. R. (1998) Clinical, parasitological and histopathologic follow-up studies of acute Chagas patients treated with benznidazole. Arch. Inst. Cardiol. Mex. 68, 405-410 (Pubitemid 28498570)
5. Bastos, C. J., Aras, R., Mota, G., Reis, F., Dias, J. P., de Jesus, R. S., Freire, M. S., de Araújo, E. G., Prazeres, J., and Grassi, M. F. (2010) Clinical outcomes of thirteen patients with acute Chagas disease acquired through oral transmission from two urban outbreaks in northeastern Brazil. PLoS Negl. Trop. Dis. 4, e711
6. Urbina, J. A. (2010) Specific chemotherapy of Chagas disease: relevance, current limitations and new approaches. Acta Trop. 115, 55-68
7. Maya, J. D., Orellana, M., Ferreira, J., Kemmerling, U., López-Muñoz, R., and Morello, A. (2010) Chagas disease: Present status of pathogenic mechanisms and chemotherapy. Biol. Res. 43, 323-331
8. Marin-Neto, J. A., Cunha-Neto, E., Maciel, B. C., and Simões, M. V. (2007) Pathogenesis of chronic Chagas heart disease. Circulation 115, 1109-1123 (Pubitemid 46679556)
9. Saravia, S. G., Haberland, A., Bartel, S., Araujo, R., Valda, G., Reynaga, D. D., Ramirez, I. D., Borges, A. C., Wallukat, G., and Schimke, I. (2011) Cardiac troponin T measured with a highly sensitive assay for diagnosis and monitoring of heart injury in chronic Chagas disease. Arch. Pathol. Lab. Med. 135, 243-248
10. Rassi, A., Jr., Rassi, A., Little, W. C., Xavier, S. S., Rassi, S. G., Rassi, A. G., Rassi, G. G., Hasslocher-Moreno, A., Sousa, A. S., and Scanavacca, M. I. (2006) Development and validation of a risk score for predicting death in Chagas' heart disease. N. Engl. J. Med. 355, 799-808 (Pubitemid 44285585)
11. Rassi, A., Jr., Rassi, A., and Marin-Neto, J. A. (2010) Chagas disease. Lancet 375, 1388-1402
12. Sabatine, M. S., Morrow, D. A., de Lemos, J. A., Gibson, C. M., Murphy, S. A., Rifai, N., McCabe, C., Antman, E. M., Cannon, C. P., and Braunwald, E. (2002) Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide. Circulation 105, 1760-1763 (Pubitemid 34408881)
13. Stanley, B. A., Gundry, R. L., Cotter, R. J., and Van Eyk, J. E. (2004) Heart disease, clinical proteomics and mass spectrometry. Dis. Markers 20, 167-178 (Pubitemid 39314347)
14. Zacks, M. A., Wen, J. J., Vyatkina, G., Bhatia, V., and Garg, N. (2005) An overview of chagasic cardiomyopathy: pathogenic importance of oxidative stress. An. Acad. Bras. Cienc. 77, 695-715
15. Gupta, S., Wen, J. J., and Garg, N. J. (2009) Oxidative Stress in Chagas Disease. Interdiscip. Perspect. Infect. Dis. 2009, 190354
16. Schijman, A. G., Vigliano, C. A., Viotti, R. J., Burgos, J. M., Brandariz, S., Lococo, B. E., Leze, M. I., Armenti, H. A., and Levin, M. J. (2004) Trypanosoma cruzi DNA in cardiac lesions of Argentinean patients with end-stage chronic chagas heart disease. Am. J. Trop. Med. Hyg. 70, 210-220 (Pubitemid 38200528)
17. da Silveira, A. B., Arantes, R. M., Vago, A. R., Lemos, E. M., Adad, S. J., Correa-Oliveira, R., and D'Avila Reis, D. (2005) Comparative study of the presence of Trypanosoma cruzi kDNA, inflammation and denervation in chagasic patients with and without megaesophagus. Parasitology 131, 627-634 (Pubitemid 41577936)
18. Wen, J. J., Bhatia, V., Popov, V. L., and Garg, N. J. (2006) Phenyl-alpha-tert-butyl nitrone reverses mitochondrial decay in acute Chagas disease. Am. J. Pathol. 169, 1953-1964 (Pubitemid 351181957)
19. Wen, J. J., Vyatkina, G., and Garg, N. (2004) Oxidative damage during chagasic cardiomyopathy development: Role of mitochondrial oxidant release and inefficient antioxidant defense. Free Radic. Biol. Med. 37, 1821-1833 (Pubitemid 39441066)
20. Wen, J. J., Dhiman, M., Whorton, E. B., and Garg, N. J. (2008) Tissue-specific oxidative imbalance and mitochondrial dysfunction during Trypanosoma cruzi infection in mice. Microbes Infect. 10, 1201-1209
21. Wen, J. J., and Garg, N. J. (2008) Mitochondrial generation of reactive oxygen species is enhanced at the Q(o) site of the complex III in the myocardium of Trypanosoma cruzi-infected mice: beneficial effects of an antioxidant. J. Bioenerg. Biomembr. 40, 587-598
22. Wen, J. J., and Garg, N. J. (2010) Mitochondrial complex III defects contribute to inefficient respiration and ATP synthesis in the myocardium of Trypanosoma cruzi-infected mice. Antioxid. Redox. Signal. 12, 27-37
23. Wen, J. J., Gupta, S., Guan, Z., Dhiman, M., Condon, D., Lui, C., and Garg, N. J. (2010) Phenyl-alpha-tert-butyl-nitrone and benzonidazole treatment controlled the mitochondrial oxidative stress and evolution of cardiomyopathy in chronic chagasic rats. J. Am. Coll. Cardiol. 55, 2499-2508
24. Dhiman, M., Nakayasu, E. S., Madaiah, Y. H., Reynolds, B. K., Wen, J. J., Almeida, I. C., and Garg, N. J. (2008) Enhanced nitrosative stress during Trypanosoma cruzi infection causes nitrotyrosine modification of host proteins: implications in Chagas' disease. Am. J. Pathol. 173, 728-740
25. Wen, J. J., Yachelini, P. C., Sembaj, A., Manzur, R. E., and Garg, N. J. (2006) Increased oxidative stress is correlated with mitochondrial dysfunction in chagasic patients. Free Rad. Biol. Med. 41, 270-276 (Pubitemid 44202395)
26. de Oliveira, T. B., Pedrosa, R. C., and Filho, D. W. (2007) Oxidative stress in chronic cardiopathy associated with Chagas disease. Int. J. Cardiol. 116, 357-363
27. Floyd, R. A., Hensley, K., Forster, M. J., Kelleher-Anderson, J. A., and Wood, P. L. (2002) Nitrones as neuroprotectants and antiaging drugs. Ann. N.Y. Acad. Sci. 959, 321-329 (Pubitemid 34457572)
28. Berger, F., De Meulder, B., Gaigneaux, A., Depiereux, S., Bareke, E., Pierre, M., De Hertogh, B., Delorenzi, M., and Depiereux, E. (2010) Functional analysis: evaluation of response intensities-tailoring ANOVA for lists of expression subsets. BMC Bioinformatics 11, 510
29. Levine, R. L., Garland, D., Oliver, C. N., Amici, A., Climent, I., Lenz, A. G., Ahn, B. W., Shaltiel, S., and Stadtman, E. R. (1990) Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol. 186, 464-478 (Pubitemid 20279989)
30. Wen, J. J., and Garg, N. (2004) Oxidative modifications of mitochondrial respiratory complexes in response to the stress of Trypanosoma cruzi infection. Free Radic. Biol. Med. 37, 2072-2081
31. Yu, H. L., Chertkow, H. M., Bergman, H., and Schipper, H. M. (2003) Aberrant profiles of native and oxidized glycoproteins in Alzheimer plasma. Proteomics 3, 2240-2248 (Pubitemid 37414088)
32. Thomas, S., and Bonchev, D. (2010) A survey of current software for network analysis in molecular biology. Hum. Genomics 4, 353-360
33. Dhiman, M., Estrada-Franco, J. G., Pando, J. M., Ramirez-Aguilar, F. J., Spratt, H., Vasquez-Corzo, S., Perez-Molina, G., Gallegos-Sandoval, R., Moreno, R., and Garg, N. J. (2009) Increased myeloperoxidase activity and protein nitration are indicators of inflammation in chagasic patients. Clin. Vaccine Immunol. 16, 660-666
34. Tanowitz, H. B., Machado, F. S., Jelicks, L. A., Shirani, J., de Carvalho, A. C., Spray, D. C., Factor, S. M., Kirchhoff, L. V., and Weiss, L. M. (2009) Perspectives on Trypanosoma cruzi-induced heart disease (Chagas disease). Prog. Cardiovasc. Dis. 51, 524-539
35. Junqueira, C., Caetano, B., Bartholomeu, D. C., Melo, M. B., Ropert, C., Rodrigues, M. M., and Gazzinelli, R. T. (2010) The endless race between Trypanosoma cruzi and host immunity: lessons for and beyond Chagas disease. Expert Rev. Mol. Med. 12, e29
36. Gupta, S., Bhatia, V., Wen, J. J., Wu, Y., Huang, M. H., and Garg, N. J. (2009) Trypanosoma cruzi infection disturbs mitochondrial membrane potential and ROS production rate in cardiomyocytes. Free Radic. Biol. Med. 47, 1414-1421
37. Ba, X., Gupta, S., Davidson, M., and Garg, N. J. (2010) Trypanosoma cruzi induces ROS-PARP-1-RelA pathway for up regulation of cytokine expression in cardiomyocytes. J. Biol. Chem. 285, 11596-11606
38. Ribeiro, C. M., Budni, P., Pedrosa, R. C., Farias, M. S., Parisotto, E. B., Dalmarco, E. M., Fröde, T. S., Oliveira-Silva, D., Colepicolo, P., and Filho, D. W. (2010) Antioxidant therapy attenuates oxidative insult caused by benzonidazole in chronic Chagas' heart disease. Int. J. Cardiol. 145, 27-33
39. Souza, A. P., Jelicks, L. A., Tanowitz, H. B., Olivieri, B. P., Medeiros, M. M., Oliveira, G. M., Pires, A. R., Santos, A. M., and Araújo-Jorge, T. C. (2010) The benefits of using selenium in the treatment of Chagas disease: prevention of right ventricle chamber dilatation and reversion of Trypanosoma cruzi-induced acute and chronic cardiomyopathy in mice. Mem. Inst. Oswaldo Cruz. 105, 746-751
40. Dhiman, M., and Garg, N. J. (2010) Role of NADPH oxidase in progression of myocarditis during Trypanosoma cruzi infection and Chagas disease. Circulation submitted
41. Guiñazu, N., Carrera-Silva, E. A., Becerra, M. C., Pellegrini, A., Albesa, I., and Gea, S. (2010) Induction of NADPH oxidase activity and reactive oxygen species production by a single Trypanosoma cruzi antigen. Int. J. Parasitol. 40, 1531-1538
42. Yan, X., Habedanck, R., and Nigg, E. A. (2006) A complex of two centrosomal proteins, CAP350 and FOP, cooperates with EB1 in microtubule anchoring. Mol. Biol. Cell 17, 634-644 (Pubitemid 43191099)
43. Patel, H., Truant, R., Rachubinski, R. A., and Capone, J. P. (2005) Activity and subcellular compartmentalization of peroxisome proliferator- activated receptor alpha are altered by the centrosome-associated protein CAP350. J. Cell Sci. 118, 175-186 (Pubitemid 40282547)
44. Qi, C., Zhu, Y., and Reddy, J. K. (2000) Peroxisome proliferator- activated receptors, coactivators, and downstream targets. Cell Biochem. Biophys. 32, 187-204
45. Szatmari, I., Töröcsik, D., Agostini, M., Nagy, T., Gurnell, M., Barta, E., Chatterjee, K., and Nagy, L. (2007) PPARgamma regulates the function of human dendritic cells primarily by altering lipid metabolism. Blood 110, 3271-3280 (Pubitemid 350106320)
46. Carter, J. C., and Church, F. C. (2009) Obesity and Breast Cancer: The roles of peroxisome proliferator-activated receptor-gamma and plasminogen activator inhibitor-1. PPAR Res. 2009, 345320
47. Rakhshandehroo, M., Knoch, B., Muller, M., and Kersten, S. (2010) Peroxisome proliferator-activated receptor alpha target genes. PPAR Res. 2010, 612089
48. Diez, D., Wheelock, A. M., Goto, S., Haeggström, J. Z., Paulsson-Berne, G., Hansson, G. K., Hedin, U., Gabrielsen, A., and Wheelock, C. E. (2010) The use of network analyses for elucidating mechanisms in cardiovascular disease. Mol. Biosyst. 6, 289-304
49. Silacci, P., Mazzolai, L., Gauci, C., Stergiopulos, N., Yin, H. L., and Hayoz, D. (2004) Gelsolin superfamily proteins: key regulators of cellular functions. Cell. Mol. Life Sci. 61, 2614-2623 (Pubitemid 39586521)
50. Koya, R. C., Fujita, H., Shimizu, S., Ohtsu, M., Takimoto, M., Tsujimoto, Y., and Kuzumaki, N. (2000) Gelsolin inhibits apoptosis by blocking mitochondrial membrane potential loss and cytochrome c release. J. Biol. Chem. 275, 15343-15349 (Pubitemid 30337262)
51. Oikonomou, N., Thanasopoulou, A., Tzouvelekis, A., Harokopos, V., Paparountas, T., Nikitopoulou, I., Witke, W., Karameris, A., Kotanidou, A., Bouros, D., and Aidinis, V. (2009) Gelsolin expression is necessary for the development of modelled pulmonary inflammation and fibrosis. Thorax 64, 467-475
52. Yang, J., Moravec, C. S., Sussman, M. A., DiPaola, N. R., Fu, D., Hawthorn, L., Mitchell, C. A., Young, J. B., Francis, G. S., McCarthy, P. M., and Bond, M. (2000) Decreased SLIM1 expression and increased gelsolin expression in failing human hearts measured by high-density oligonucleotide arrays. Circulation 102, 3046-3052
53. Li, G. H., Shi, Y., Chen, Y., Sun, M., Sader, S., Maekawa, Y., Arab, S., Dawood, F., Chen, M., De Couto, G., Liu, Y., Fukuoka, M., Yang, S., Da Shi, M., Kirshenbaum, L. A., McCulloch, C. A., and Liu, P. (2009) Gelsolin regulates cardiac remodeling after myocardial infarction through DNase I-mediated apoptosis. Circ. Res. 104, 896-904
54. Richard, P., Charron, P., Carrier, L., Ledeuil, C., Cheav, T., Pichereau, C., Benaiche, A., Isnard, R., Dubourg, O., Burban, M., Gueffet, J. P., Millaire, A., Desnos, M., Schwartz, K., Hainque, B., and Komajda, M. (2003) Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy. Circulation 107, 2227-2232 (Pubitemid 36547217)
55. Poetter, K., Jiang, H., Hassanzadeh, S., Master, S. R., Chang, A., Dalakas, M. C., Rayment, I., Sellers, J. R., Fananapazir, L., and Epstein, N. D. (1996) Mutations in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscle. Nat. Genet. 13, 63-69 (Pubitemid 26139295)
56. Flavigny, J., Richard, P., Isnard, R., Carrier, L., Charron, P., Bonne, G., Forissier, J. F., Desnos, M., Dubourg, O., Komajda, M., Schwartz, K., and Hainque, B. (1998) Identification of two novel mutations in the ventricular regulatory myosin light chain gene (MYL2) associated with familial and classical forms of hypertrophic cardiomyopathy. J. Mol. Med. 76, 208-214 (Pubitemid 28098707)
57. Kabaeva, Z. T., Perrot, A., Wolter, B., Dietz, R., Cardim, N., Correia, J. M., Schulte, H. D., Aldashev, A. A., Mirrakhimov, M. M., and Osterziel, K. J. (2002) Systematic analysis of the regulatory and essential myosin light chain genes: genetic variants and mutations in hypertrophic cardiomyopathy. Eur. J. Hum. Genet. 10, 741-748 (Pubitemid 35460584)
58. Cunha-Neto, E., Dzau, V. J., Allen, P. D., Stamatiou, D., Benvenutti, L., Higuchi, M. L., Koyama, N. S., Silva, J. S., Kalil, J., and Liew, C. C. (2005) Cardiac gene expression profiling provides evidence for cytokinopathy as a molecular mechanism in Chagas' disease cardiomyopathy. Am. J. Pathol. 167, 305-313 (Pubitemid 43026088)
59. Goldenberg, R. C., Iacobas, D. A., Iacobas, S., Rocha, L. L., da Silva de Azevedo Fortes, F., Vairo, L., Nagajyothi, F., Campos de Carvalho, A. C., Tanowitz, H. B., and Spray, D. C. (2009) Transcriptomic alterations in Trypanosoma cruzi-infected cardiac myocytes. Microbes Infect. 11, 1140-1149
60. Leon, J. S., and Engman, D. M. (2001) Autoimmunity in Chagas heart disease. Int. J. Parasitol. 31, 555-561 (Pubitemid 32382055)
61. Leon, J. S., Daniels, M. D., Toriello, K. M., Wang, K., and Engman, D. M. (2004) A cardiac myosin-specific autoimmune response is induced by immunization with Trypanosoma cruzi proteins. Infect. Immun. 72, 3410-3417 (Pubitemid 38697766)
62. Katsumoto, T., Mitsushima, A., and Kurimura, T. (1990) The role of the vimentin intermediate filaments in rat 3Y1 cells elucidated by immunoelectron microscopy and computer-graphic reconstruction. Biol. Cell 68, 139-146 (Pubitemid 20139587)
63. Faé, K. C., Diefenbach da Silva, D., Bilate, A. M., Tanaka, A. C., Pomerantzeff, P. M., Kiss, M. H., Silva, C. A., Cunha-Neto, E., Kalil, J., and Guilherme, L. (2008) PDIA3, HSPA5 and vimentin, proteins identified by 2-DE in the valvular tissue, are the target antigens of peripheral and heart infiltrating T cells from chronic rheumatic heart disease patients. J. Autoimmun. 31, 136-141
64. Teixeira, P. C., Iwai, L. K., Kuramoto, A. C., Honorato, R., Fiorelli, A., Stolf, N., Kalil, J., and Cunha-Neto, E. (2006) Proteomic inventory of myocardial proteins from patients with chronic Chagas' cardiomyopathy. Braz. J. Med. Biol. Res. 39, 1549-1562 (Pubitemid 46357840)